Clinical Trials Browser

Phase 1 × Breast Neoplasms, Male × Imatinib Mesylate × Clear all

NCT00080665 2018-04-24

Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male